封面
市场调查报告书
商品编码
1766583

局部止痛药市场:按产品类型、按活性成分、按类型、按应用、按患者细分、按分销管道、按地区

Topical Pain Relief Market, By Product Type, By Active Ingredient, By Type, By Application, By Patient Demographics, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

局部止痛药市场规模预计在 2025 年达到 111 亿美元,预计到 2032 年将达到 159.3 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 5.3%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 111亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 5.30% 2032年价值预测 159.3亿美元

近年来,全球局部疼痛缓解市场经历了显着增长,这得益于慢性疼痛疾病患病率的上升、老年人口的增长以及人们对局部疼痛管理解决方案益处的认识的不断提高。局部疼痛缓解产品透过将活性成分直接施用于患处来缓解局部疼痛,最大限度地减少全身暴露并降低与口服止痛药相关的副作用风险。市场提供各种各样的产品,包括乳膏、凝胶、喷雾剂、贴剂和软膏,配製时含有各种活性成分,包括非类固醇消炎剂(NSAID)、薄荷醇、辣椒素和Lidocaine。随着越来越多的消费者寻求安全有效的急性和慢性疼痛管理方法,局部止痛药的需求预计将继续增长。

市场动态

全球局部止痛药市场受多种因素驱动,包括关节炎、背痛和运动伤害等慢性疼痛疾病的盛行率不断上升,这些疾病需要长期的疼痛管理解决方案。全球老年人口的成长也促进了市场的成长,因为老年人更容易患上慢性疼痛。此外,人们对口服止痛药副作用的认识不断提高,导致消费者偏好转向局部止痛药,因为这类药物能够缓解局部疼痛,对全身的影响最小。然而,口服药物和物理治疗等替代性疼痛管理方案的出现,以及某些局部用药产品对严重疼痛的疗效有限,可能会抑制市场的成长。此外,对新型止痛外用药核准的严格监管准则也可能对市场进入者构成挑战。儘管存在这些市场限制,但对天然和有机止痛产品日益增长的需求、新型药物输送系统的市场开发以及包括电商平台在内的分销渠道的不断拓展,正在为市场带来巨大的增长机会。

本研究的主要特点

  • 本报告对全球局部止痛药市场进行了详细分析,并提供了预测期(2025-2032 年)的市场规模(十亿美元)和年复合成长率(CAGR%),假设 2024 年为基准年。
  • 它还强调了各个领域的潜在商机,并解释了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、业绩和策略等参数列出了全球局部止痛药市场的主要企业简介。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员将透过用于分析全球局部止痛药市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 限制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业趋势

4. 2020 年至 2032 年全球局部止痛药市场(依产品类型)

  • 凝胶
  • 奶油
  • 软膏
  • 修补
  • 滚珠式

5. 2020 年至 2032 年全球局部止痛药市场(依活性成分划分)

  • 非类固醇消炎剂(NSAID)
  • 抗刺激
  • 麻醉剂
  • 水杨酸盐
  • 辣椒素
  • 薄荷醇

6. 2020 年至 2032 年全球局部止痛药市场(按类型)

  • 处方止痛药
  • 非处方止痛药

7. 2020 年至 2032 年全球局部止痛药市场(按应用)

  • 关节炎疼痛
  • 肌肉和关节疼痛
  • 下背部疼痛
  • 运动伤害
  • 神经病变疼痛
  • 术后疼痛

8. 全球局部止痛药市场(依病患细分),2020 年至 2032 年

  • 成人
  • 老年人
  • 孩子们

9. 全球局部止痛药市场(依通路划分),2020 年至 2032 年

  • 网路药局
  • 零售药局
  • 医院药房
  • 超级市场/大卖场
  • 健康与保健商店

10. 全球局部止痛药市场(按地区划分),2020-2032 年

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第十一章竞争格局

  • Johnson & Johnson
  • Pfizer Inc.
  • GlaxoSmithKline
  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma Inc.
  • Mylan NV
  • Reckitt Benckiser Group plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Mentholatum Company, Inc.

第 12 章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十三章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8051

Topical Pain Relief Market is estimated to be valued at USD 11.10 Bn in 2025 and is expected to reach USD 15.93 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.10 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.30% 2032 Value Projection: USD 15.93 Bn

The global topical pain relief market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic pain conditions, rising geriatric population, and growing awareness about the benefits of topical pain management solutions. Topical pain relief products offer localized pain relief by delivering active ingredients directly to the affected area, minimizing systemic exposure and reducing the risk of adverse effects associated with oral pain medications. The market encompasses a wide range of products, including creams, gels, sprays, patches, and ointments, formulated with various active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs), menthol, capsaicin, and lidocaine. The demand for topical pain relief products is expected to continue growing as more consumers seek safe and effective options for managing acute and chronic pain conditions.

Market Dynamics

The global topical pain relief market is driven by several factors, including the rising prevalence of chronic pain conditions, such as arthritis, back pain, and sports injuries, which require long-term pain management solutions. The growing geriatric population worldwide is also contributing to the market growth, as older adults are more susceptible to chronic pain conditions. Moreover, the increasing awareness about the side effects associated with oral pain medications has led to a shift in consumer preference towards topical pain relief products, which offer localized pain relief with minimal systemic exposure. However, the market growth may be restrained by the availability of alternative pain management options, such as oral medications and physical therapy, as well as the limited efficacy of some topical products for severe pain conditions. Additionally, stringent regulatory guidelines for the approval of new topical pain relief products may pose challenges for market players. Despite these restraints, the market presents significant opportunities for growth, driven by the increasing demand for natural and organic pain relief products, the development of novel drug delivery systems, and the expansion of distribution channels, including e-commerce platforms.

Key Features of the Study

  • This report provides in-depth analysis of the global topical pain relief market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global topical pain relief market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Johnson & Johnson, Pfizer Inc., GlaxoSmithKline, Bayer AG, Novartis AG, Sanofi S.A., Merck & Co., Inc., Abbott Laboratories, Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Reckitt Benckiser Group plc, Hisamitsu Pharmaceutical Co., Inc., and Mentholatum Company, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global topical pain relief market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical pain relief market.

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Gels
    • Creams
    • Ointments
    • Patches
    • Sprays
    • Roll-ons
  • Active Ingredient Insights (Revenue, USD Bn, 2020 - 2032)
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • Counterirritants
    • Anesthetics
    • Salicylates
    • Capsaicin
    • Menthol
  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Prescription Pain Relief
    • Over-the-Counter (OTC) Pain Relief
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Arthritis Pain
    • Muscle and Joint Pain
    • Back Pain
    • Sports Injuries
    • Neuropathic Pain
    • Post-Surgical Pain
  • Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
    • Adults
    • Geriatrics
    • Pediatrics
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Online Pharmacies
    • Retail Pharmacies
    • Hospitals Pharmacy
    • Supermarkets/Hypermarkets
    • Health and Wellness Stores
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Johnson & Johnson
    • Pfizer Inc.
    • GlaxoSmithKline
    • Bayer AG
    • Novartis AG
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Abbott Laboratories
    • Amgen Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Astellas Pharma Inc.
    • Mylan N.V.
    • Reckitt Benckiser Group plc
    • Hisamitsu Pharmaceutical Co., Inc.
    • Mentholatum Company, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Topical Pain Relief Market, By Product Type
    • Global Topical Pain Relief Market, By Active Ingredient
    • Global Topical Pain Relief Market, By Type
    • Global Topical Pain Relief Market, By Application
    • Global Topical Pain Relief Market, By Patient Demographics
    • Global Topical Pain Relief Market, By Distribution Channel
    • Global Topical Pain Relief Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Topical Pain Relief Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Creams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Roll-ons
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Topical Pain Relief Market, By Active Ingredient, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Counterirritants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Salicylates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Capsaicin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Menthol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Topical Pain Relief Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription Pain Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Over-the-Counter (OTC) Pain Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Topical Pain Relief Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Arthritis Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Muscle and Joint Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Back Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sports Injuries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neuropathic Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Post-Surgical Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Topical Pain Relief Market, By Patient Demographics, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Topical Pain Relief Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hospitals Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Supermarkets/Hypermarkets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Health and Wellness Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Topical Pain Relief Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astellas Pharma Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reckitt Benckiser Group plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mentholatum Company, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us